The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
DIsCOvER: A multicenter, randomized, double-blind, placebo-controlled, phase III clinical trial to investigate the efficacy and safety of dronabinol in the improvement of chemotherapy-induced and tumor-related symptoms in patients with locally advanced or metastatic pancreas cancer during first-line chemotherapy.
 
Felix Keil
No Relationships to Disclose
 
Georg Schreil
No Relationships to Disclose
 
Thamer Sliwa
No Relationships to Disclose
 
Meinolf Karthaus
Consulting or Advisory Role - Amgen
Travel, Accommodations, Expenses - Amgen
 
Adelheid Seebacher
No Relationships to Disclose
 
Harald Werner Weiss
No Relationships to Disclose
 
Beate Mayrbaeurl
No Relationships to Disclose
 
Rudolf Likar
No Relationships to Disclose
 
Ewald Woell
No Relationships to Disclose
 
Claudio Denzlinger
No Relationships to Disclose
 
Richard Greil
No Relationships to Disclose